Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. DaVita Inc.
  6. Summary
    DVA   US23918K1088

DAVITA INC.

(DVA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/21/2021 09/22/2021 09/23/2021 09/24/2021 09/27/2021 Date
119.85(c) 121.11(c) 122.1(c) 121(c) 122.11 Last
803 930 649 123 758 832 584 970 160 539 Volume
-0.08% +1.05% +0.82% -0.90% +0.92% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 11 632 M - -
Net income 2021 1 003 M - -
Net Debt 2021 9 856 M - -
P/E ratio 2021 13,2x
Yield 2021 1,17%
Sales 2022 12 095 M - -
Net income 2022 991 M - -
Net Debt 2022 10 214 M - -
P/E ratio 2022 12,5x
Yield 2022 1,21%
Capitalization 12 681 M 12 681 M -
EV / Sales 2021 1,94x
EV / Sales 2022 1,89x
Nbr of Employees 67 000
Free-Float 92,6%
More Financials
Company
DaVita Inc., formerly DaVita HealthCare Partners Inc., operates one division: DaVita Kidney Care (Kidney Care). The Kidney Care division consists of the Company's United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. The Company's segments include U.S. dialysis and related lab services and... 
More about the company
Ratings of DaVita Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about DAVITA INC.
09/16DAVITA KIDNEY CARE : Names New Chief Nursing Officer
PR
09/09DAVITA INC. : Change in Directors or Principal Officers (form 8-K)
AQ
09/09DAVITA : Cowen Initiates DaVita With Market Perform Rating, $145 Price Target
MT
09/09DAVITA : Announces Dr. Gregory Moore to Join its Board of Directors
PR
09/09DaVita Inc. Appoints Gregory Moore to its Board of Directors and to Serve on its Nomina..
CI
08/13NORTH AMERICAN MORNING BRIEFING : Blockbuster -3-
DJ
08/12DAVITA : Barclays Downgrades DaVita to Equal-Weight From Overweight, Adjusts Price Target ..
MT
08/09DAVITA : Insiders Make Significant Stock Sales in DaVita (DVA) Shares Extending the Trend ..
MT
08/06INSIDER TRENDS : Insider Adds to Selling Trend at DaVita
MT
08/06INSIDER TRENDS : DaVita Insider Extends 90-Day Selling Trend
MT
08/04DAVITA : RBC Raises Price Target on DaVita to $113 From $108 'to Reflect Improving Visibil..
MT
08/03DAVITA : Management's Discussion and Analysis of Financial Condition and Results of Operat..
AQ
08/03DAVITA : Q2 Results Top Street Expectations, Raises 2021 EPS Guidance Above Consensus Esti..
MT
08/03DAVITA : 2nd Quarter 2021 Results (Form 8-K)
PU
08/03DAVITA : Earnings Flash (DVA) DAVITA Reports Q2 EPS $2.64, vs. Street Est of $2.16
MT
More news
News in other languages on DAVITA INC.
07/16MÄRKTE EUROPA/Kaum Bewegung bei Aktien - Jenoptik sehr fest
2019FRESENIUS/FMC IM FOKUS : Auf Kurs - Mit Risiken und Nebenwirkungen
2019AKTIE IM FOKUS : FMC unter schwächsten Dax-Werten - Sorgen um US-Dialysegeschäft
2019US-Apothekenkette CVS will in den Heimdialyse-Markt - FMC-Aktie unter Druck
2019Aktien Frankfurt: Moderate Verluste - Anlegern fehlt weiter der Mut zum Kauf
More news
Analyst Recommendations on DAVITA INC.
More recommendations
Chart DAVITA INC.
Duration : Period :
DaVita Inc. Technical Analysis Chart | DVA | US23918K1088 | MarketScreener
Technical analysis trends DAVITA INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 10
Last Close Price 121,00 $
Average target price 140,89 $
Spread / Average Target 16,4%
EPS Revisions
Managers and Directors
Javier J. Rodriguez Chief Executive Officer & Director
Joel Ackerman Chief Financial Officer
Pamela M. Arway Chairman
Jeff Giullian Chief Medical Officer
James O. Hearty Chief Compliance Officer
Sector and Competitors